AIM
ONC

Aigen Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Aigen Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,957
Closed -$1.35M – 1122
2025
Q1 		$1.35M Buy
4,957
+2,242
+83% +$524K 0.22% 141
2024
Q4 		$501K Buy
+2,715
New +$555K 0.09% 330
2024
Q1 		– Sell
-1,635
Closed -$295K – 1066
2023
Q4 		$295K Buy
+1,635
New +$296K 0.05% 493
2023
Q2 		– Sell
-2,335
Closed -$503K – 1005
2023
Q1 		$503K Buy
+2,335
New +$560K 0.07% 310
2022
Q1 		– Sell
-703
Closed -$201K – 1166
2021
Q4 		$201K Buy
+703
New +$237K 0.01% 934
2021
Q1 		– Sell
-5,684
Closed -$1.47M – 931
2020
Q4 		$1.47M Buy
+5,684
New +$1.56M 0.19% 136

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return